Sofinnova Partners is an independent venture capital firm from Paris, France that provides funding for seed, early stage and late stage ventures. Founded in 1972, the firm has financed and has partnered with almost 500 companies. They invest in companies in the life science sector, especially those that work with biopharmaceuticals, biotech, medical devices, and industrial biotechnology. It usually invests in Round A, and leads its portfolio companies until exit.
The company prioritizes projects with strong intellectual property and whose founders have pharmaceutical or industrial experience. They invest in start-ups usually from the academic world, as well as spin-offs.
Founded in 1974, Sofinnova is a clinical-stage biopharmaceutical investment firm headquartered in Menlo Park, California. The firm seeks to invest in late pre-clinical and clinical therapeutic companies across the United States and Europe.
Sofinnova Ventures partners with entrepreneurs to secure initial funding, help their partner companies build successful teams, find customers, and help them complete acquisitions and IPOs.
Sofinnova Ventures invests in Life Science and Technology start-ups. Their professionals are business operators with domain and investment experience. Sofinnova knows how to help entrepreneurs build successful, global businesses.
Associated investment funds
Funding Rounds Participated In
Partner, Sofinnova Telethon Fund
Alan colowick, MD MPH
Vice President Finance
Documentaries, videos and podcasts
- Venture capitalVenture capital is a form of private equity financing that is provided by venture capital firms or funds to startups, early-stage, and emerging companies that have been deemed to have high growth potential or which have demonstrated high growth. Capital invested usually carries a substantial element of risk.